A University of Virginia School of Medicine scientist has received a $6.5 million grant to develop the “lymphatic medicine exam of the future” to improve care for chronic swelling, known as lymphedema, and other lymphatic diseases. 

BUFFALO, NY — July 27, 2026 — A new research paper was published in Volume 18 of Aging on July 13, 2026, titled “Slowing intervertebral disc aging in mice through long-term systemic treatment with the senolytic BCL-2/BCL-xL proteolysis targeting chimera (PROTAC) 753b.”

The University of Tennessee, Knoxville, welcomes Carolyn J. Anderson, an internationally recognized radiopharmaceutical researcher, as a UT-Oak Ridge National Laboratory Governor’s Chair. In this role, Anderson will research the potential of ORNL-produced radioisotopes for cancer treatment and will translate new knowledge and discoveries into solutions, often in collaboration with colleagues at the UT Health Science Center.

University of Missouri researchers are turning  a variety of purple colored corn traditionally grown in South America into an effective natural alternative to artificial food dyes. Unlike artificial dyes, which are petroleum-based and added purely for appearance, these natural pigments are rich in antioxidants known for reducing inflammation and supporting heart health.

Enrico M. Novelli, MD, MS, has been named Director of the University of Maryland School of Medicine (UMSOM) Program in Sickle Cell Disease and a Professor in the Department of Medicine, Division of Hematology/Oncology. An internationally recognized expert in sickle cell disease, he will treat patients at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) and serve as Chief of the University of Maryland Medical System (UMMS) Sickle Cell Disease and Classical Hematology Network, a new initiative to expand access to care for patients with sickle cell disease across Maryland.